Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Microneedle patches could replace injections but need more development for better use in medicine.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

The new drug delivery system effectively targets lung cancer cells.

Extracellular vesicles could help tailor drug treatments, but more research is needed.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Mutations in the spike protein affect drug binding and effectiveness.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Smart microneedles can deliver drugs painlessly and accurately for diseases like diabetes and tumors.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Illite can effectively carry minoxidil for hair growth without causing scalp irritation.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.